Moody Aldrich Partners »

Upstream Bio shares owned by Moody Aldrich Partners

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by Moody Aldrich Partners from 13F filings

Historical chart of Moody Aldrich Partners investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by Moody Aldrich Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by Moody Aldrich Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.2M 75k 16.44

More positions owned by Moody Aldrich Partners

Cadence Bank (CADE)
Independent Bank (INDB)
Protagonist Therapeutics (PTGX)
Kratos Defense & Sec Solutio Com New (KTOS)
Piper Jaffray Companies (PIPR)
Meta Financial (CASH)
Modine Manufacturing (MOD)
Element Solutions (ESI)
Merus N V (MRUS)
Core Scientific (CORZ)
Riot Blockchain (RIOT)
Columbia Banking System (COLB)
Scorpio Tankers SHS (STNG)
Cargurus Com Cl A (CARG)
VSE Corporation (VSEC)

View all positions for Moody Aldrich Partners

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
Decheng Capital
BlackRock
Enavate Sciences GP
Vanguard Group
Bain Capital Life Sciences Investors
TCG Crossover Management
Altshuler Shaham
Omega Fund Management
VR Adviser
Wellington Management Company
State Street Corporation
Samsara BioCapital
Marshall Wace

View all funds holding Upstream Bio